Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: Beta-blockers and Prostate Cancer Survival - Interpretation of Competing Risks Models.

Bhaskaran, K; Rachet, B; Evans, S; Smeeth, L; (2013) Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: Beta-blockers and Prostate Cancer Survival - Interpretation of Competing Risks Models. European urology, 64 (4). e86-7. ISSN 0302-2838 DOI: https://doi.org/10.1016/j.eururo.2013.07.004

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar